Generics 12

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Edoxaban tosylate manufacturers

12 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

12 products found

edoxaban tosylate

Tablets 15 mg, 30 mg, 60 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Manufacturer #21496

This CTD dossier owner and manufacturer is a fully integrated pharmaceutical corporation with a global reach. The company specializes in CMO and CDMO pharmaceutical preparations in a variety of dosage forms for a variety of therapeutic categories. GSK, Pfizer, Sanofi, Novartis, Mylan, Apotex, Adcock Ingram, and other MNCs manufacture formulations in various dosage forms for customers in 55 countries in important markets such as Europe, Australia & New Zealand, Canada, Japan, Far East Asia, GCC, Africa, LATAM, and CIS.

Manufacturer usually replies in 1 days

edoxaban tosylate

Tablets 15 mg, 30 mg , 60 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Antigua And/Or Barbuda , Argentina , Bahamas , Barbados , Belize , Bolivia , Brazil , Chile , Colombia , Costa Rica , Cuba , Dominica , Dominican Republic , Ecuador , El Salvador , Grenada , Guatemala , Guyana , Haiti , Honduras , Jamaica , Mexico , Nicaragua , Panama , Paraguay , Peru , Suriname , Uruguay , Venezuela
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 2 days

edoxaban tosylate

Tablets, immediate release (IR) 15 mg, 30 mg, 60 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP, WHO, MHRA, Canada
Comments
Dossier availability: Canada, Europe, United Kingdom, Latin America, Emerging Market
Manufacturer #16394
This healthcare company is a prominent player in the pharmaceutical industry, specializing in a wide range of products including Active Pharmaceutical Ingredients (APIs), Biosimilars, Injectables, Ophthalmics, Peptides, and Solid Orals. They have a strong presence in both domestic and international markets, particularly in the EU and North America. The company boasts a diverse portfolio across several key therapy areas, with particular strength in Cardiovascular health and Oral Anti-Diabetic (OAD) medications. Their manufacturing facilities adhere to stringent GMP certifications, ensuring high quality standards. They also hold numerous product patents, highlighting their commitment to innovation.

Manufacturer usually replies in 2 days

Want to see all 12 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible